481 related articles for article (PubMed ID: 31735345)
1. Diffuse large B-cell lymphoma variants: an update.
Sukswai N; Lyapichev K; Khoury JD; Medeiros LJ
Pathology; 2020 Jan; 52(1):53-67. PubMed ID: 31735345
[TBL] [Abstract][Full Text] [Related]
2. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
[TBL] [Abstract][Full Text] [Related]
3. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.
Grimm KE; O'Malley DP
Ann Diagn Pathol; 2019 Feb; 38():6-10. PubMed ID: 30380402
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
[TBL] [Abstract][Full Text] [Related]
5. A fulminant case of classical Hodgkin lymphoma: A diagnostic dilemma of Epstein-Barr virus-positive large B-cell neoplasms.
Ichimata S; Kobayashi M; Ohya M; Otsuki T; Yanagisawa K; Tateishi K; Kato A; Matsuo A; Kanno H
Pathol Int; 2019 Jul; 69(7):407-413. PubMed ID: 31215109
[TBL] [Abstract][Full Text] [Related]
6. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management.
Castillo JJ; Beltran BE; Miranda RN; Young KH; Chavez JC; Sotomayor EM
Am J Hematol; 2018 Jul; 93(7):953-962. PubMed ID: 29984868
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
[TBL] [Abstract][Full Text] [Related]
8. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review.
Marques-Piubelli ML; Salas YI; Pachas C; Becker-Hecker R; Vega F; Miranda RN
Pathology; 2020 Jan; 52(1):40-52. PubMed ID: 31706670
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
Stuhlmann-Laeisz C; Szczepanowski M; Borchert A; Brüggemann M; Klapper W
Virchows Arch; 2015 Jan; 466(1):85-92. PubMed ID: 25339301
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations.
Hristov AC
Arch Pathol Lab Med; 2012 Aug; 136(8):876-81. PubMed ID: 22849734
[TBL] [Abstract][Full Text] [Related]
12. EBV+ cutaneous B-cell lymphoproliferation of the leg in an elderly patient with mycosis fungoides and methotrexate treatment.
Rausch T; Cairoli A; Benhattar J; Spring P; Hohl D; de Leval L
APMIS; 2013 Jan; 121(1):79-84. PubMed ID: 23031074
[TBL] [Abstract][Full Text] [Related]
13. EBV positivity in primary cutaneous large B-cell lymphoma with immunophenotypic features of leg type: an isolated incident or something more significant?
Gaitonde S; Kavuri S; Alagiozian-Angelova V; Peace D; Worobec S
Acta Oncol; 2008; 47(3):461-4. PubMed ID: 17896194
[No Abstract] [Full Text] [Related]
14. Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified, in a nonimmunocompromised young man: A case report.
Mo XL; Zhou MY; Ye QR
J Cutan Pathol; 2020 Apr; 47(4):387-389. PubMed ID: 31658378
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer.
Ikeda T; Gion Y; Sakamoto M; Tachibana T; Nishikori A; Nishimura MF; Yoshino T; Sato Y
Mod Pathol; 2020 Dec; 33(12):2437-2448. PubMed ID: 32561847
[TBL] [Abstract][Full Text] [Related]
16. A distinctive subgroup of oral EBV+ B-cell neoplasm with polymorphous features is potentially identical to EBV+ mucocutaneous ulcer.
Ohata Y; Tatsuzawa A; Ohyama Y; Ichikawa A; Mochizuki Y; Ishibashi S; Itakura Y; Sakurai U; Sakamoto K; Ikeda T; Kitagawa M; Yamamoto K
Hum Pathol; 2017 Nov; 69():129-139. PubMed ID: 28993276
[TBL] [Abstract][Full Text] [Related]
17. The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.
Menon MP; Pittaluga S; Jaffe ES
Cancer J; 2012; 18(5):411-20. PubMed ID: 23006945
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma: a rare and aggressive cutaneous lymphoma.
Vermeesch J; Ramirez J; Lafond A
Cutis; 2018 Dec; 102(6):421-424. PubMed ID: 30657800
[TBL] [Abstract][Full Text] [Related]
19. Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?
Ok CY; Ye Q; Li L; Manyam GC; Deng L; Goswami RR; Wang X; Montes-Moreno S; Visco C; Tzankov A; Dybkaer K; Zhang L; Abramson J; Sohani AR; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhang S; Parsons BM; Xu M; Møller MB; Winter JN; Piris MA; Xu-Monette ZY; Medeiros LJ; Young KH
Oncotarget; 2015 Jun; 6(16):13933-45. PubMed ID: 26101854
[TBL] [Abstract][Full Text] [Related]
20. Aggressive B-cell lymphomas: frequency, immunophenotype, and genetics in a reference laboratory population.
Naeini YB; Wu A; O'Malley DP
Ann Diagn Pathol; 2016 Dec; 25():7-14. PubMed ID: 27806850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
